While I see generative AI emerging as healthcare’s most transformative disruptor, its full potential relies on robust data ...

digital twins have the potential to transform patient care, streamline drug discovery, and promote proactive healthcare. The two parallel technologies that have been growing in related areas of ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: Drug discovery companies ...

Staffing shortages, rising costs, efforts to reduce administrative burden on clinicians and other factors are leading many ...

Health care is one of the most promising sectors ... The second looks at the cutting edge of AI in the life sciences, where speeding up drug discovery could mean getting life-saving therapies ...

Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...

The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of biomedical ...

Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, widely lagging the 2.41% gain of the broad-based S&P 500® index.